Clinico-pathologic function of cerebral ABC transporters - Implications for the pathogenesis of Alzheimer's disease

Jens Pahnke*, Olaf Wolkenhauer, Markus Krohn, Lary C. Walker

*Corresponding author for this work

Research output: Contribution to journalReview article / Perspectivespeer-review

38 Scopus citations

Abstract

In recent years it has become evident that ABC transporters fulfill important barrier functions in normal organs and during disease processes. Most importantly, resistance to drugs in cancer cells led to intense oncological and pharmacological investigations in which researchers were able to highlight important pharmacological interactions of chemotherapeuticals with ABC transporter function. Recently, the development of neurodegenerative diseases and the maintenance of neuronal stem cells have been linked to the activity of ABC transporters. Here, we summarize findings from cell culture experiments, animal models and studies of patients with Alzheimer's disease. Furthermore, we discuss pharmacological interactions and computational methods for risk assessment.

Original languageEnglish
Pages (from-to)396-405
Number of pages10
JournalCurrent Alzheimer Research
Volume5
Issue number4
DOIs
StatePublished - Aug 2008
Externally publishedYes

Keywords

  • ABC transporter
  • Abeta
  • Alzheimer's disease
  • BCRP
  • Blood-brain barrier
  • Dementia
  • MDR1
  • MRP1
  • Neurodegeneration
  • P-glycoprotein
  • Systems biology

Fingerprint

Dive into the research topics of 'Clinico-pathologic function of cerebral ABC transporters - Implications for the pathogenesis of Alzheimer's disease'. Together they form a unique fingerprint.

Cite this